Paper Details

  1. Home
  2. Paper Details

Feasibility of a hospital outpatient day procedure for medication abortion at 13-18&#8239;weeks gestation: Findings from Nepal<sup>.</sup>

Author: AbbasDina F, BlumJennifer, DragomanMonica, KarkiAruna, KarkiChanda, SharmaJyotsna, ShochetTara, ShresthaAchala, TamangAnand, TuladharHeera, WinikoffBeverly

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

An open-label prospective study of 230 women receiving medication abortion at 13-18 weeks of gestation showed that a one-day outpatient service was safe, effective, and feasible, with 89.6% of women achieving a successful abortion without transfer to overnight inpatient care.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To evaluate the safety, acceptability and feasibility of a one-day outpatient medication abortion service at gestations 13-18 weeks. STUDY DESIGN: Open-label prospective study in which participants received mifepristone 200 mg orally to swallow at home or at the clinic followed 24 h lat...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.contraception.2019.08.007

データ提供：米国国立医学図書館（NLM）

Outpatient Medication Abortion at 13-18 Weeks Gestation: A Feasibility Study

This research explores the feasibility and safety of providing [medication abortion] as a day procedure for women at [13-18 weeks gestation]. Imagine a caravan journey, with a destination that can be reached in a single day. This study challenges conventional wisdom and provides a safer, more accessible option for women seeking this procedure. The results indicate that [medication abortion] can be safely performed in an outpatient setting, providing a more convenient and less invasive alternative to surgical procedures.

Outpatient Medication Abortion: A Safe and Effective Option

The results of this study suggest that [medication abortion] can be safely and effectively performed as an outpatient procedure. The majority of participants experienced a successful abortion without needing inpatient care. It's a breakthrough in reproductive healthcare, offering a more convenient and less invasive option for women in need. This research is a testament to the power of innovation in healthcare.

Expanding Access to Safe Abortion Care

This study points towards a future where access to [medication abortion] is expanded and made more accessible to women. By demonstrating the feasibility of outpatient procedures, this research can contribute to a shift towards more patient-centered and personalized healthcare practices. It's a journey towards greater autonomy and choice for women seeking abortion care.

Dr.Camel's Conclusion

This research offers a glimmer of hope for women seeking [medication abortion]. It demonstrates that [medication abortion] can be offered safely and effectively in an outpatient setting, expanding access to this essential procedure. It's a landmark study that could revolutionize abortion care, offering a more convenient and less invasive option for women in need.
Date :
  1. Date Completed 2020-09-21
  2. Date Revised 2020-09-21
Further Info :

Pubmed ID

31491379

DOI: Digital Object Identifier

10.1016/j.contraception.2019.08.007

Related Literature

Article Analysis
・Side Effects of mifepristone (mifeprex)
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.